Trial Details
Not RecruitingBasic Information
| Clinical ID | c2120 |
|---|---|
| Identifier | ACTRN12623001337662 |
| Trial Title | Concentrations of Thioguanine and its metabolite 6TGN in Blood and Rectal Tissue Samples in Patients with Refractory Ulcerative Proctitis Administered Thioguanine by Suppository |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | inflammatory Bowel Disease; inflammatory Bowel Disease;Oral and Gastrointestinal - Inflammatory bowel disease |
| Interventions | Administration of thioguanine by suppository once daily, 5mg or 20mg as determined by computer randomisation, rectally for 29 days. Adherence monitored by product return, and pharmacokinetics on day 1 and day 29. |
Participant Information
| Sponsor | Douglas Pharmaceuticals |
|---|---|
| City | - |
| Country/Region | New Zealand |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |